Steno Diabetes Center Odense
16
7
7
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
13%
2 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Type 1 Diabetes and Diabetes Distress
Role: collaborator
A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes
Role: collaborator
MDT Conferences for People With Diabetes and Multimorbidity
Role: collaborator
LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers
Role: collaborator
Digital Individualized and Collaborative Treatment of T2D in General Practice Based on Decision Aid
Role: collaborator
Semaglutide Treatment in Type 1 Diabetes
Role: collaborator
National Trial of CGM in Pregnant Women With Type 2 Diabetes
Role: collaborator
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Role: collaborator
Neurofeedback for the Management of Neuropathic Pain in People with Diabetes
Role: collaborator
Face-it: Health Promotion for Women With Prior Gestational Diabetes
Role: collaborator
Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
Role: collaborator
Sleep, Obesity and Mental Disease - Biological Markers for the Evaluation of Circadian Rhythmicity
Role: collaborator
the Type ONe dIabetic Bone Collaboration Study
Role: collaborator
Covid-19 Infection and New Onset Type 1 Diabetes
Role: collaborator
South Danish Obesity Initiative, Screening for Unrecognized Obesity Related Disease
Role: collaborator
Arterial Composition and Cardiovascular Outcome in DIabeteS
Role: collaborator
All 16 trials loaded